Basel Medical Group Ltd Ordinary Shares Cash Flow-to-Debt Ratio
Basel Medical Group Ltd Ordinary Shares cash flow-to-debt ratio. Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2026, meaning its operating cash flow of $-1.63 Million could theoretically repay 0% of its total liabilities ($13.60 Million) in one year. Check BMGL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Basel Medical Group Ltd Ordinary Shares (2022–2025)
Cash flow-to-debt ratio of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025. Historical debt coverage capacity for Basel Medical Group Ltd Ordinary Shares across 4 annual periods. Check total reinvestment intensity of Basel Medical Group Ltd Ordinary Shares to assess the company's total reinvestment commitment from operating cash flow.
Basel Medical Group Ltd Ordinary Shares Cash Flow-to-Debt Ratio by Year (2022–2025)
Basel Medical Group Ltd Ordinary Shares cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for Basel Medical Group Ltd Ordinary Shares. For the full cash flow conversion analysis, see Basel Medical Group Ltd Ordinary Shares cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-4.34 Million | $11.99 Million | ▼ -226.3% |
| 2024 | 0.29x | $2.51 Million | $8.75 Million | ▲ +9.1% |
| 2023 | 0.26x | $2.60 Million | $9.89 Million | ▲ +23.7% |
| 2022 | 0.21x | $2.79 Million | $13.14 Million | — |